Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
25 participants
OBSERVATIONAL
2020-02-03
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts.
Objective:
To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice.
Eligibility:
Swiss experts in the field of assisted suicide
Design:
The study includes 25 interviews that have already been conducted. The participants were:
* academics
* doctors and others in medical care
* a government official
* representatives of right-to-die societies.
Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Effects of Chemical Interactions in Toxicity
NCT00253773
Metabolic Analysis in Human Sulfur Amino Acid Deficiency
NCT00253760
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
NCT05241262
Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?
NCT01692639
Survey on Supplement Use in Mitochondrial Disease
NCT02311257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
people who are not physicians. All other countries that have adopted aid-in-dying legislation
require that a physician provides this assistance. This project probes the reasons for adopting this policy, and the advantages and the disadvantages of the Swiss model at the end of life. Are the Swiss aid-in-dying volunteers able to provide well-informed assistance to patients in need? Is the Swiss model one to be followed by other nations? The project will focus on the work of the Swiss aid-in-dying societies. The study draws on research in the fields of ethics, law and medicine. Its novelty lies in incorporating different methods of analysis, reflecting on the right to die with dignity within a liberal framework that aims to respect fundamental human rights.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experts in Swiss assisted suicide
Persons in Switzerland who are experts in how assisted suicide is practiced. We will beexamining already collected interviews.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender: Men 14, Women 11
* Backgrounds of interviewees: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1
* Race and ethnicity: All white Swiss.
* Age range: Unknown, but all are adults.
* No vulnerable populations.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health Clinical Center (CC)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Y Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institutes of Health Clinical Center (CC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-CC-N059
Identifier Type: -
Identifier Source: secondary_id
999920059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.